Vadadustat

Item number	Size	Delivery time	Price
TGM-T4651-1mg	1 mg	7 - 10 business days*	40.00€
TGM-T4651-1mL	1 ml	7 - 10 business days*	94.00€
TGM-T4651-5mg	5 mg	7 - 10 business days*	94.00€
TGM-T4651-10mg	10 mg	7 - 10 business days*	148.00€
TGM-T4651-25mg	25 mg	7 - 10 business days*	245.00€
TGM-T4651-50mg	50 mg	7 - 10 business days*	378.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase... more

Close menu

Product information "Vadadustat"

Description: Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia. Target: HIF, HIF/HIF Prolyl-Hydroxylase. Smiles: OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1. References: Pergola PE, et al. Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease. Kidney Int. 2016 Nov,90(5):1115-1122.

Keywords:	PG-1016548, AKB-6548
Supplier:	TargetMol
Supplier-Nr:	T4651

Properties

Application:	Targets hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] (EGLN, HPH)
MW:	306.7 D
Formula:	C14H11ClN2O4
Format:	32160405

Database Information

CAS :	1000025-07-9\| Matching products
KEGG ID :	K09592 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Vadadustat"

Write a review